Interestingly, a well-known gene fusion in prostate cancer that is produced by deletion of a 3-mega base region between ERG and TMPRSS2[52] (also reviewed in [Parker 2014 Journal of Pathology]) has also been found to upregulate ZEB1 and ZEB2 expression [53]. This evidence concerns the gene ZEB2 and prostate carcinoma.